An independent body that offers guidance to improve health and social care in England recommended against the use of axicabtagene ciloleucel, one of...
Day: 30 August 2018
Could a Blood Test Help Clinicians Diagnose Multiple Myeloma Earlier?
There may be a way to detect multiple myeloma (MM) earlier — effectively shortening the longer diagnostic interval that is typically associated with...
Expert Reflects on “Incredible” Data Seen With bb2121 in Heavily Pretreated Myeloma
The deep and durable phase I responses seen with the anti-BCMA chimeric antigen receptor (CAR) T-cell therapy bb2121 in patients with...